abstract |
According to the present invention, an iron-deficiency anemia treatment agent containing iron and diprotose is provided. Iron and diprotose contained in the anemia treatment agent may form a complex, and the molar ratio is between 1: 0.5 and 1: 1,000.n n n In addition, the anemia treatment agent of the present invention may further include hematopoietic factors such as cyanocobalamine, pyridoxine hydrochloride, folic acid, and the like. |